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Abstract 
BACKGROUND: Bekasam is one of the traditional foods in South Sumatra, Indonesia, a mixture of fermented 
fish containing Lactic Acid Bacteria (LAB), Lactobacillus sp. Non-commensal bacteria and probiotics can induce 
intestinal mucosal immune responses. 
AIM: This pilot study aimed to see the efficacy of Lactobacillus sp. to the immune response of the intestinal 
mucosa by assessing the levels of IgA in the intestinal fluid and markers of T cell populations, such as CD4 and 
CD8 in the intestinal mucosa. 
METHODS: This study was an in vivo experimental study. As many as 30 rats were grouped into 3 treatment 
groups (doses 107, 108, and 109 CFU/rat/day, for 7 days) and 2 groups of controls (negative control, 10% non-fat 
milk, and positive control, Lactobacillus casei 108 CFU/rat/day for 7 days). At the end of the treatment, the 
intestinal mucosa was taken to examine the levels of IgA, CD4 and CD8 using the Enzyme-Linked 
Immunosorbent Assay (ELISA) method, according to the manuals of each ELISA kit. All displays of research data 
were presented with means ± SD. T-test was used to assess the significance of differences.  
RESULTS: Secretion of Ig A increased with the addition of Lactobacillus sp. from bekasam. Administration of 
Lactobacillus sp. yielded no effect on helper T cell level (CD4 markers), as well as on cytotoxic T cell levels (CD8 
markers). 
CONCLUSION: Lactobacillus sp. probiotic from bekasam improved the intestinal mucosal immune system by 
increasing the production of Ig A, but exhibited no effect on T lymphocyte cells. 
 
 
 
Introduction 
 
The immune system plays a role in the body's 
defence against the threat of invasion or infection from 
various pathogenic microorganisms. The immune 
system consists of innate and adaptive, both of which 
will induce a systemic and mucosal immune response. 
In the intestinal mucosa, the innate immune response 
acts not only as an initial defence of microorganisms 
but also induces activation of the adaptive immune 
response. Non-commensal bacteria and probiotics 
can induce intestinal mucosal immune responses [1]. 
Macrophages and dendritic cells play a major 
role in initiating innate immune responses, which will 
specialise into phagocytic cells. Phagocytic cells 
possess receptor patterns able to recognise 
pathogenic molecules found on the surface of 
pathogenic cells. These receptors will be activated by 
pathogens [2]. 
One family receptor that operates in the 
introduction of pathogen molecules is the Toll-like 
receptor (TLR). TLR plays an important role in the 
body's defence warning system against the presence 
of pathogenic material [3]. TLR activates innate 
immune responses, especially inflammation, before 
the activation of the adaptive response system [4], [5]. 
TLR-2 can recognise microbial components such as 
lipoprotein/lipopeptides from various pathogens and 
able to detect the presence of peptidoglycan and 
lipoteichoic acid from gram-positive bacteria. TLR-2 
can recognise lipopolysaccharide (LPS) from 
enterobacteria such as Leptospira interrogans, 
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Porphyromonas gingivalis and Helicobacter pylori [6], 
[7]. 
Another family that operates in the 
introduction of molecular pathogens is the mannequin 
receptor family. CD-206 is a mannose family receptor 
that plays a role in the clearance of self-antigens such 
as endogenous proteins, myeloperoxidase, lysosomal 
hydrolase and several hormones that contain groups 
of sulfated carbohydrate [8]. This receptor binds to a 
group of carbohydrates containing mannosyl/fucosyl 
residues so that it can recognise proteoglycans from 
microbial origins [9]. 
Bekasam is one of the traditional foods in 
South Sumatra, Indonesia. This food is a mixture of 
fermented fish. Bekasam contains Lactic Acid 
Bacteria (LAB), Lactobacillus sp. [10]. Several studies 
show the role of probiotic, especially LAB, as a major 
component in maintaining health and preventing 
various diseases. Consumption of probiotics is useful 
in managing diarrhoea, including antibiotic-induced 
diarrhoea and diarrhoea in children commonly caused 
by rotavirus [11], [12], [13]. Innate immune 
components interplay with intestinal epithelial cells 
and bacteria [14]. Probiotics had also been proven to 
benefit in urogenital health [15], improvement of the 
periodontal condition [16], chronic colitis [17], 
inflammatory bowel disease [18], [19], and even to 
prevent or reduce the incidence of oral and respiratory 
tract infections in paediatrics [20]. 
Probiotic microorganisms are supplements of 
living bacteria to maintain the balance of bacteria in 
the intestine. Lactobacillus sp. is a microorganism 
commonly used as probiotics. Probiotics can stimulate 
the secretion of immunoglobulin (Ig) A in the intestine. 
Also, probiotics can increase the secretion of 
proinflammatory cytokines such as tumour necrosis 
factor (TNF) alpha and increase regulatory 
inflammatory cytokines such as interleukin (IL)-4 and 
IL-10 [21]. 
This pilot study aimed to see the efficacy of 
Lactobacillus sp. to the immune response of the 
intestinal mucosa by assessing the levels of IgA in the 
intestinal fluid and markers of T cell populations, such 
as CD4 and CD8 in the intestinal mucosa. 
 
 
Material and Methods 
 
This study was an in vivo experimental study. 
As many as 30 rats (age 10 weeks, body weight 180-
200 gr) Rattus norvegicus were used in this study. 
Each treatment and control group consisted of 6 rats. 
Each rat was supplied with food and drink in ad 
libitum. This study was approved by the research 
ethics committee of the Faculty of Medicine, 
Universitas Sriwijaya-RSMH (kpt fkunsri-rsmh no. 
113/2018). Furthermore, rats were grouped into 3 
treatment groups (doses 10
7
, 10
8
, and 10
9
 CFU / 
rat/day, for 7 days) and 2 groups of controls (negative 
control, 10% non-fat milk, and positive control, 
Lactobacillus casei 10
8
 CFU / rat/day for 7 days). 
Probiotics were administered by 1 mL of sterile 10% 
non-fat milk. 
Bekasam was composed by mixing 1 kg of 
fish with 3% salt and 250 grams of rice. Furthermore, 
the mixture was wrapped with plastic tightly and left 
for 8 days at room temperature (28-34°C). Bacteria 
derived from samples were grown into MRSA media. 
Of these bacterial cultures, colonies that grew 
dominant with different morphology, both in terms of 
color, shape as observed from the top, and shape of 
the protrusion were taken into the media of Man 
Rogosa Sharpe Agar (MRSA) and morphology the cell 
was observed. At the end of the treatment, the rat was 
killed by anesthesia, and the intestine was evacuated. 
Furthermore, the intestinal mucosa was taken to 
examine the levels of IgA, CD4 and CD8 using the 
Enzyme-Linked Immunosorbent Assay (ELISA) 
method, according to the manuals of each ELISA kit 
(Cloud-Clone Corp®, Texas, USA). 
Statistical analysis was conducted with SPSS 
for Windows (SPSS Inc., Chicago, Illinois, USA). All 
displays of research data were presented with means 
± SD. T-test was used to assess the significance of 
differences between treatment and control groups. 
 
 
Results 
 
Secretion of Ig A increased with the addition 
of Lactobacillus sp. from bekasam. Efficacy of 
Lactobacillus sp. in increasing levels of Ig A at 10
9
 
CFU dose was greater than the positive control group 
with Lactobacillus casei at a dose of 10
8
 CFU. In the 
group with Lactobacillus sp. at a dose of 10
8
 CFU 
possessed the effect of increased Ig A production 
almost comparable to the control group with 
Lactobacillus casei at a dose of 10
8
 CFU, although 
statistically, the increase in the positive control group 
was slightly greater than the treatment group receiving 
Lactobacillus sp. at dose of 10
8
 CFU. Table 1 showed 
that Lactobacillus probiotic administration elevated Ig 
A secretion in the intestinal mucosa. 
Table 1: Level of IgA in Intestinal Mucosa 
Group Level (ng/mL) p-Value 
Treatment 10
7 
CFU 94.186.21 0.021*. 0.027
#
 
Treatment 10
8 
CFU 124.838.55 0.001*. 0.043
#
 
Treatment 10
9 
CFU 189.1110.17 0.001*. 0.001
#
 
Negative control 91.233.45 0.001
#
 
Positive control 125.239.23 0.001* 
*Independent T test VS negative control; 
# 
Independent T test VS positive control. 
Lactobacillus sp. probiotic possessed no 
effect on T cells in the intestinal mucosa (Table 2). 
Administration of Lactobacillus sp. yielded no effect on 
helper T cell level, which was characterised by CD4 
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markers, as well as no effect on cytotoxic T cell levels, 
which was marked by CD8 markers. 
Table 2: Level of CD4 and CD8 in Intestinal Mucosa 
Group Level CD4 
(ng/mL) 
Level CD8 
(ng/mL) 
p-Value CD4 p-Value CD8 
Treatment 10
7 
CFU 23.18 ± 8.28 22.18 ± 6.28 0.17*. 0.11
#
 0.37*. 0.31
#
 
Treatment 10
8 
CFU 23.63 ± 7.15 24.83 ± 7.15 0.11*. 0.32
#
 0.21*. 0.31
#
 
Treatment 10
9 
CFU 23.91 ± 7.76 23.11 ± 8.16 0.15*. 0.18
#
 0.11*. 0.21
#
 
Negative control 21.43 ± 8.01 21.23 ± 6.01 0.14
#
 0.21
#
 
Positive control 22.73 ± 6.29 22.23 ± 5.29 0.21* 0.16* 
*Independent T test VS negative control; 
# 
Independent T test VS positive control. 
 
 
 
Discussion 
 
Epithelial surface of the intestine is the area 
contacting with intestinal commensal microorganisms, 
which play a role in optimising the immune system. 
The surface of the gastrointestinal epithelium also 
always confronts various external microorganisms. 
This condition causes a significant role of the 
intestinal mucosa as a defence against invasion from 
various microorganisms. An effective defence 
mechanism is in dire need to maintain the 
homeostasis of the intestinal mucosa. One defence 
mechanism in the intestinal mucosa is through the 
production of IgA antibodies. Whereas, protective 
microflora will protect the intestinal mucosa from the 
invasion of pathogenic microorganisms. Protective 
microflora in the intestinal mucosa will stimulate the 
proliferation of epithelial cells and the development of 
the mucosal immune system [6], [14]. 
Intestinal epithelial cells are the first defence 
against various bacterial invasions and various 
products of pathogenic bacteria, especially in apical 
epithelial cells. Whereas at the basolateral side of 
epithelial cells, immune cells are present. Epithelial 
cells are capable of introducing components of 
bacterial structures that are in contact with the 
intestine so that they will be able to recognise these 
bacteria as pathogens or non-pathogens [3]. Non-
pathogenic probiotic bacteria originating from food can 
affect the mucosal immune system in the intestine. 
Contact between these microorganisms and epithelial 
cells as well as immune cells in Peyer's patches of the 
intestine will trigger immune cells such as 
monocytes/macrophages and dendritic cells to initiate 
an innate immune response and antigenic stimulation. 
The basic functions of the mucosal immune system 
include protection from various pathogens, preventing 
penetration of various foreign antigens, inducing oral 
tolerance to various antigens and maintaining 
mucosal homeostasis. The main difference between 
the mucosal immune system and the adaptive 
immune system is in the presence of innate immunity 
and the activation of B cells rather than T cells [22]. 
Probiotic species alone do not result in a 
clinical effect; rather, they facilitate modulation of the 
gut microbiota composition and metabolic activity, 
thereby influencing the immune response [23]. 
Probiotic bacteria interact with the intestinal epithelial 
cells (IECs) or immune cells associated with the 
lamina propria, through Toll-like receptors, and induce 
the production of different cytokines or chemokines. 
Macrophage chemoattractant protein 1, produced by 
the IECs, sends signals to other immune cells leading 
to the activation of the MIS, characterised by an 
increase in immunoglobulin A+ cells of the intestine, 
bronchus and mammary glands, and the activation of 
T cells. Specifically, probiotics activate regulatory T 
cells that release IL-10. Interestingly, probiotics 
reinforce the intestinal barrier by an increase of the 
mucins, the tight junction proteins and the Goblet and 
Paneth cells. Another proposed mechanism of 
probiotics is the modulation of intestinal microbiota by 
maintaining the balance and suppressing the growth 
of potentially pathogenic bacteria in the gut [24]. 
This study was the first study to observe the 
efficacy of Lactobacillus sp. from typical fermented 
foods of South Sumatra, Indonesia (Bekasam) to the 
optimisation of the mucosal immune system in the 
intestine. This study showed Lactobacillus sp. 
probiotic elevated Ig A production in the intestinal 
mucosa but possessed no effect on T lymphocyte 
cells, which was characterised by no significant effect 
of Lactobacillus sp. probiotic to the expression of CD4 
and CD8 in the intestinal mucosa. The administration 
of Lactobacillus casei in this study also exhibited a 
similar result to the administration of Lactobacillus sp. 
from bekasam. They improved the mucosal immune 
system by increasing the secretion of IgA but 
exhibited no effect on T lymphocyte cells.  
In conclusion, Lactobacillus sp. probiotic from 
bekasam improved the intestinal mucosal immune 
system by increasing the production of Ig A. Efficacy 
of Lactobacillus sp. in increasing levels of Ig A was 
comparable to Lactobacillus casei. Lactobacillus sp. 
probiotic possessed no effect on T cells in the 
intestinal mucosa. Administration of Lactobacillus sp. 
yielded no effect on helper T cell level, which was 
characterised by CD4 markers, as well as no effect on 
cytotoxic T cell levels, which was marked by CD8 
markers. 
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